Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Implementing a zero based budgeting plan can streamline your finances. Learn the key steps to create an effective budget plan today.
22,407 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Investors chasing quantum headlines often overlook how a big subscription software player can deliver durable AI-and-...
Investors eye SpaceX's potential IPO as the space economy broadens; public peers already provide exposure across laun...
AI chips are reshaping tech, and ARM Holdings could ride the wave as a major royalty player. This article explains wh...
AST SpaceMobile and Globalstar chart divergent paths toward 2026 as they push new revenue streams and cash flow.
A notable fund just built a fresh position in a cloud security leader. Discover the numbers behind winmill loads qual...
Adobe is navigating a fast-changing software landscape in 2026. This guide breaks down the 2026 earnings outlook, key...
A high-conviction bet on a Chinese logistics platform faced a sharp stock drop. This article explains why the fund wa...
A recent move shows Bamco expanding its exposure to FactSet, highlighting the power of subscription-based data platfo...
The GTLB story has investors buzzing about whether a rebound is ahead. Even as revenue trends stay strong, the stock ...
Two AI powerhouses, two very different bets. This guide compares Nvidia and Palantir to help you decide which path fi...
SpaceX IPO chatter has investors buzzing about windfalls for insiders and thousands of workers with equity. This repo...